EMA launches clinical trial map to enhance research access
The European Medicines Agency (EMA) has implemented a new clinical trial mapping tool within the Clinical Trials Information System (CTIS), marking a significant development in the accessibility of EU clinical trial data. The tool, launched as part of the Accelerating Clinical Trials in the European Union initiative's 2025-2026 workplan, enables healthcare professionals and patients to search for ongoing trials by location and medical condition, with functionality for lay language queries and spelling corrections. The system provides direct investigator contact information for trial enrolment enquiries and will initially operate in English, with additional EU language support planned. This development advances the transparency objectives of the Clinical Trials Regulation, whilst maintaining the existing framework where EU/EEA Member States retain authority over trial authorisation and oversight, with the European Commission maintaining regulatory supervision.